Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila

J Antimicrob Chemother. 2002 May;49(5):857-61. doi: 10.1093/jac/dkf017.

Abstract

The intracellular activity of ABT-773 against Legionella pneumophila was compared with azithromycin and ciprofloxacin using HL-60 cells. Against L. pneumophila ATCC 33152 and three clinical isolates the MICs (mg/L) were ABT-773 0.015, ciprofloxacin 0.03 and azithromycin 0.03. At 48 h, the mean percentage inhibition was as follows: 28.5 +/- 5.9% and 32.6 +/- 4.6% at 8 x and 16 x MIC of ABT-773; 38.1 +/- 8.6% and 48.2 +/- 7.0% at 8 x and 16 x MIC of ciprofloxacin; and 26.3 +/- 9.9% and 28.5 +/- 9.9% at 8 x and 16 x MIC of azithromycin. In this study, all three agents were highly active, with ABT-773 demonstrating similar activity to azithromycin against L. pneumophila.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / pharmacology
  • Ciprofloxacin / pharmacology
  • Erythromycin / analogs & derivatives*
  • Erythromycin / pharmacology*
  • HL-60 Cells
  • Humans
  • Ketolides*
  • Legionella pneumophila / drug effects*
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Ketolides
  • Ciprofloxacin
  • Erythromycin
  • Azithromycin
  • cethromycin